The Geneva Foundation

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, The Geneva Foundation sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 3 currently recruiting 2 completed top decile by trial count

The Geneva Foundation: 11 sponsored US clinical trials, 3 recruiting.

The Geneva Foundation sponsors 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is COVID-19 Acute Respiratory Distress Syndrome, with 2 trials.

Top-decile sponsor footprint

The Geneva Foundation ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the The Geneva Foundation pipeline

3 recruiting of 11 indexed (27% open); 2 completed (18%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: COVID-19 Acute Respiratory Distress Syndrome (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The Geneva Foundation: open-pipeline peers nationwide

Peers matched on 11 registered trials and 27% open enrollment, not the therapeutic-area sidebar.

The Geneva Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30% Total trials Recruiting share The Geneva FoundationAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeConnecticut Children's Medical CenterCriteriumMinneapolis Heart Institute FoundationNerviano Medical Sciences
The Geneva Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The Geneva Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 27% open enrollment (± trial volume)

What to do with this The Geneva Foundation page

11 registered trials is a research-attention snapshot, not an endorsement of The Geneva Foundation or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The Geneva Foundation pipeline card: 11 registered trials from official public datasets.Report a data error.